NS

Nitinaben Sandipbhai Patel

Active Director Director DIN 09420061
DIN 09420061 First appointment Dec 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Nitinaben Sandipbhai Patel

Data last updated:

Nitinaben Sandipbhai Patel is a Director at Richly Pharmaceuticals Private Limited (since 2021). The company operates in Pharma.

DIN 09420061
Primary Designation Director
Industry Pharma
First Appointment 01 Dec 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Dec 20212021Active

Board colleagues of Nitinaben Sandipbhai Patel

Directorship timeline

Open interactive timeline →
Richly Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Nitinaben Sandipbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nitinaben Sandipbhai Patel

Nitinaben Sandipbhai Patel currently holds 1 directorship: Richly Pharmaceuticals Private Limited (Director, since 01 Dec 2021).

Nitinaben Sandipbhai Patel was first appointed on 01 Dec 2021 as Director at Richly Pharmaceuticals Private Limited.

The current boards of Nitinaben Sandipbhai Patel's companies include Sandipkumar Chandubhai Patel (Richly Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available